Last updated on April 2018

Prismaflex HF20 Set and Prismaflex System 7.10 for Acute CRRT in Children


Brief description of study

The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to effectively treat acute kidney injury (AKI) in pediatric patients by reducing blood urea nitrogen (BUN).

Clinical Study Identifier: NCT02561247

Contact Investigators or Research Sites near you

Start Over

Rick Hackbarth, MD

Helen DeVos Children's Hospital
Grand Rapids, MI United States
  Connect »

Raymond Quigley, MD

Children's Medical Center of Dallas
Dallas, TX United States
  Connect »

Raj Munshi, MD

Seattle Children's Hospital - Divison of Nephrology
Seattle, WA United States
  Connect »

Scott Sutherland, MD

Lucile Packard Children's Hospital Stanford
Stanford, CA United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

Children's Hospital Colorado, University of Colorado School of Medicine
Aurora, CO United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

Nemours/Alfred I. duPont Hospital for Children
Wilmington, DE United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

Holtz Children's Hospital, University of Miami
Miami, FL United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

University of Iowa Children's Hospital
Iowa City, IA United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

C.S. Mott Children's Hospital, University of Michigan
Ann Arbor, MI United States
  Connect »

Stuart L Goldstein, MD

Cincinnati Children's Hospital Medical Center
Cincinnati, OH United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

The Children's Hospital of Philadelphia
Philadelphia, PA United States
  Connect »

Baxter Clinical Trials Disclosure Call ...

Baylor Medical College, Texas Children's Hospital
Houston, TX United States
  Connect »